Tenax Therapeutics, Inc. (TENX) insider trading.
In Q3 2026, insiders at Tenax Therapeutics, Inc. reported 13 non-derivative transactions on 8 Forms 3, 4 and 5: 11 open-market purchases worth $4.9M and 0 sales.
- Transactions
- 13
- Purchases (P)
- 11
- Sales (S)
- 0
- Net shares, P minus S
- 2,765,725
- Insiders
- 5
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schneeberger Daniel / ADAR1 Capital Management, LLC | TenPercentOwner | 6 | 6 | 0 |
| Giordano Christopher Thomas | Director, Officer · CEO | 4 | 2 | 0 |
| Doogan Declan | Director | 1 | 1 | 0 |
| Staab Thomas R II | Officer · Chief Financial Officer | 1 | 1 | 0 |
| ADAR1 Capital Management, LLC / Schneeberger Daniel | TenPercentOwner | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Doogan Declan | P (A) | 53,000 | $1.92 | 55,274 | Form 4 |
| 2026-09-15 | Giordano Christopher Thomas | P (A) | 4,850 | $1.82 | 22,174 | Form 4 |
| 2026-09-11 | Staab Thomas R II | P (A) | 5,675 | $1.94 | 15,675 | Form 4 |
| 2026-09-11 | Giordano Christopher Thomas | P (A) | 6,000 | $1.88 | 17,324 | Form 4 |
| 2026-09-03 | ADAR1 Capital Management, LLC / Schneeberger Daniel | P (A) | 900,000 | $1.78 | 6,524,151 | Form 4 |
| 2026-09-02 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 187,704 | $1.8 | 5,624,151 | Form 4 |
| 2026-09-01 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 179,058 | $1.8 | 5,436,447 | Form 4 |
| 2026-08-31 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 403,571 | $1.79 | 5,257,389 | Form 4 |
| 2026-08-24 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 107,374 | $1.75 | 4,853,818 | Form 4 |
| 2026-08-21 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 716,369 | $1.77 | 4,746,444 | Form 4 |
| 2026-08-20 | Schneeberger Daniel / ADAR1 Capital Management, LLC | P (A) | 202,124 | $1.78 | 4,030,075 | Form 4 |
| 2026-07-13 | Giordano Christopher Thomas | M (A) | 219 | $3.55 | 2,824 | Form 4 |
| 2026-07-13 | Giordano Christopher Thomas | M (A) | 8,500 | $5.94 | 11,324 | Form 4 |
Transaction codes in this quarter
Get TENX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=34956&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TENX company page · Tenax Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Tenax Therapeutics, Inc. (TENX)?
In Q3 2026, insiders at Tenax Therapeutics, Inc. reported 13 non-derivative transactions on 8 Forms 3, 4 and 5: 11 open-market purchases worth $4.9M and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Tenax Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tenx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.